All Stories

  1. cGAS–STING Pathway Activation during Trypanosoma cruzi Infection Leads to Tissue-Dependent Parasite Control

    Article • The Journal of Immunology, August 2023, The American Association of Immunologists

    Dr Rick L Tarleton

  2. Effective drug discovery in Chagas disease

    Article • Trends in Parasitology, June 2023, Elsevier

    Dr Rick L Tarleton

  3. Frequency Variation and Dose Modification of Benznidazole Administration for the Treatment of Trypanosoma cruzi Infection in Mice, Dogs, and Nonhuman Primates

    Article • Antimicrobial Agents and Chemotherapy, May 2023, ASM Journals

    Dr Rick L Tarleton

  4. Validation of a multiplex microsphere immunoassay for detection ofTrypanosoma cruziantibodies in dogs

    Article • March 2023, Cold Spring Harbor Laboratory Press

    Dr Rick L Tarleton

  5. Delayed Activation of T Cells at the Site of Infection Facilitates the Establishment of Trypanosoma cruzi in Both Naive and Immune Hosts

    Article • mSphere, February 2023, ASM Journals

    Dr Rick L Tarleton

  6. Frequency variation and dose modification of benznidazole administration for the treatment ofTrypanosoma cruziinfection in mice, dogs and non-human primates

    Article • February 2023, Cold Spring Harbor Laboratory Press

    Dr Rick L Tarleton

  7. Epitopes in the Glycosylphosphatidylinositol Attachment Signal Peptide of Trypanosoma cruzi Mucin Proteins Generate Robust but Delayed and Nonprotective CD8+ T Cell Responses

    Article • The Journal of Immunology, January 2023, The American Association of Immunologists

    Dr Rick L Tarleton

  8. Avoiding Clinical Trial Failures in Neglected Tropical Diseases: The Example of Chagas Disease

    Article • Clinical Infectious Diseases, November 2022, Oxford University Press (OUP)

    Dr Rick L Tarleton

  9. Prophylactic low-dose, bi-weekly benznidazole treatment fails to prevent Trypanosoma cruzi infection in dogs under intense transmission pressure

    Article • PLoS Neglected Tropical Diseases, October 2022, PLOS

    Dr Rick L Tarleton

  10. Quantitative 3D Imaging of <em>Trypanosoma cruzi</em>-Infected Cells, Dormant Amastigotes, and T Cells in Intact Clarified Organs

    Article • Journal of Visualized Experiments, June 2022, MyJove Corporation

    Dr Rick L Tarleton

  11. High variation in immune responses and parasite phenotypes in naturally acquired Trypanosoma cruzi infection in a captive non-human primate breeding colony in Texas, USA

    Article • PLoS Neglected Tropical Diseases, March 2021, PLOS

    Dr Rick L Tarleton

  12. Strain-specific genome evolution in Trypanosoma cruzi, the agent of Chagas disease

    Article • PLoS Pathogens, January 2021, PLOS

    Dr Rick L Tarleton

  13. High variation in immune responses and parasite phenotypes in naturally acquired Trypanosoma cruzi infection in a captive non-human primate breeding colony in Texas, USA

    Article • January 2021, Cold Spring Harbor Laboratory Press

    Dr Rick L Tarleton

  14. A modified drug regimen clears active and dormant trypanosomes in mouse models of Chagas disease

    Article • Science Translational Medicine, October 2020, American Association for the Advancement of Science

    Dr Rick L Tarleton

  15. Cutting Edge: Augmenting Muscle MHC Expression Enhances Systemic Pathogen Control at the Expense of T Cell Exhaustion

    Article • The Journal of Immunology, August 2020, The American Association of Immunologists

    Dr Rick L Tarleton

  16. Strain-specific genome evolution inTrypanosoma cruzi, the agent of Chagas disease

    Article • July 2020, Cold Spring Harbor Laboratory Press

    Dr Rick L Tarleton

  17. Chagas Disease Drug Discovery: Multiparametric Lead Optimization against Trypanosoma cruzi in Acylaminobenzothiazole Series

    Article • Journal of Medicinal Chemistry, October 2019, American Chemical Society (ACS)

    Dr Rick L Tarleton

  18. Protozoan persister-like cells and drug treatment failure

    Article • Nature Reviews Microbiology, August 2019, Springer Science + Business Media

    Dr Rick L Tarleton

  19. Highly competent, non-exhausted CD8+ T cells continue to tightly control pathogen load throughout chronic Trypanosoma cruzi infection

    Article • PLoS Pathogens, November 2018, PLOS

    Dr Rick L Tarleton

  20. Spontaneous dormancy protects Trypanosoma cruzi during extended drug exposure

    Article • eLife, March 2018, eLife

    Dr Rick L Tarleton

  21. Spontaneous dormancy protects Trypanosoma cruzi during extended drug exposure

    Article • December 2017, Cold Spring Harbor Laboratory Press

    Dr Rick L Tarleton

  22. Rapid, Selection-Free, High-Efficiency Genome Editing in Protozoan Parasites Using CRISPR-Cas9 Ribonucleoproteins

    Article • mBio, November 2017, ASM Journals

    Dr Rick L Tarleton

  23. The Significance of Discordant Serology in Chagas Disease: Enhanced T-Cell Immunity to Trypanosoma cruzi in Serodiscordant Subjects

    Article • Frontiers in Immunology, September 2017, Frontiers

    Dr Rick L Tarleton

  24. Correction for Ekanayake et al., “Epigenetic Regulation of Transcription and Virulence in Trypanosoma cruzi by O-Linked Thymine Glucosylation of DNA”

    Article • Molecular and Cellular Biology, July 2017, ASM Journals

    Daniel Nilsson, Dr Rick L Tarleton

  25. Engineered trivalent immunogen adjuvanted with a STING agonist confers protection against Trypanosoma cruzi infection

    Article • npj Vaccines, April 2017, Springer Science + Business Media

    Dr Rick L Tarleton

  26. Chagas Disease: A Solvable Problem, Ignored

    Article • Trends in Molecular Medicine, October 2016, Elsevier

    Dr Rick L Tarleton

  27. Recombination-driven generation of the largest pathogen repository of antigen variants in the protozoan Trypanosoma cruzi

    Article • BMC Genomics, September 2016, Springer Science + Business Media

    Dr Rick L Tarleton

  28. Long-Term Immunity to Trypanosoma cruzi in the Absence of Immunodominanttrans-Sialidase-Specific CD8+T Cells

    Article • Infection and Immunity, June 2016, ASM Journals

    Dr Rick L Tarleton

  29. Treatment Success in Trypanosoma cruzi Infection Is Predicted by Early Changes in Serially Monitored Parasite-Specific T and B Cell Responses

    Article • PLoS Neglected Tropical Diseases, April 2016, PLOS

    Dr Rick L Tarleton

  30. A framework for ontology-based question answering with application to parasite immunology

    Article • Journal of Biomedical Semantics, July 2015, Springer Science + Business Media

    Dr Rick L Tarleton

  31. CD8+ T cells in Trypanosoma cruzi infection

    Article • Seminars in Immunopathology, April 2015, Springer Science + Business Media

    Dr Rick L Tarleton

  32. Reaching for the Holy Grail: insights from infection/cure models on the prospects for vaccines for Trypanosoma cruzi infection

    Article • Memórias do Instituto Oswaldo Cruz, April 2015, FapUNIFESP (SciELO)

    Dr Rick L Tarleton

  33. Perturbed T Cell IL-7 Receptor Signaling in Chronic Chagas Disease

    Article • The Journal of Immunology, April 2015, The American Association of Immunologists

    Dr Rick L Tarleton

  34. Chemokine receptor 7 (CCR7)-expression and IFNγ production define vaccine-specific canine T-cell subsets

    Article • Veterinary Immunology and Immunopathology, April 2015, Elsevier

    Dr Rick L Tarleton

  35. CRISPR-Cas9-Mediated Single-Gene and Gene Family Disruption in Trypanosoma cruzi

    Article • mBio, December 2014, ASM Journals

    Dr Rick L Tarleton

  36. Chagas Disease and the London Declaration on Neglected Tropical Diseases

    Article • PLoS Neglected Tropical Diseases, October 2014, PLOS

    Dr Rick L Tarleton

  37. The Trypanosoma cruzi Flagellum Is Discarded via Asymmetric Cell Division following Invasion and Provides Early Targets for Protective CD8+ T Cells

    Article • Cell Host & Microbe, October 2014, Elsevier

    Dr Rick L Tarleton

  38. Potential new clinical therapies for Chagas disease

    Article • Expert Review of Clinical Pharmacology, April 2014, Taylor & Francis

    Dr Rick L Tarleton

  39. Frequency of IFNγ-producing T cells correlates with seroreactivity and activated T cells during canine Trypanosoma cruzi infection

    Article • Veterinary Research, January 2014, Springer Science + Business Media

    Dr Rick L Tarleton

  40. Polyfunctional T Cell Responses in Children in Early Stages of Chronic Trypanosoma cruzi Infection Contrast with Monofunctional Responses of Long-term Infected Adults

    Article • PLoS Neglected Tropical Diseases, December 2013, PLOS

    Dr Rick L Tarleton

  41. Perpetual expression of PAMPs necessary for optimal immune control and clearance of a persistent pathogen

    Article • Nature Communications, October 2013, Springer Science + Business Media

    Dr Rick L Tarleton

  42. Ask the Experts: Drug discovery for the treatment of leishmaniasis, African sleeping sickness and Chagas disease

    Article • Future Medicinal Chemistry, October 2013, Future Science

    Dr Rick L Tarleton

  43. Evidence for the role of vacuolar soluble pyrophosphatase and inorganic polyphosphate inTrypanosoma cruzipersistence

    Article • Molecular Microbiology, September 2013, Wiley

    Professor Roberto Docampo, Dr Rick L Tarleton

  44. New, Combined, and Reduced Dosing Treatment Protocols Cure Trypanosoma cruzi Infection in Mice

    Article • The Journal of Infectious Diseases, August 2013, Oxford University Press (OUP)

    Dr Rick L Tarleton

  45. From Questions to Effective Answers: On the Utility of Knowledge-Driven Querying Systems for Life Sciences Data

    Article • January 2013, Springer Science + Business Media

    Dr Rick L Tarleton

  46. A Systematic Review of High Quality Diagnostic Tests for Chagas Disease

    Article • PLoS Neglected Tropical Diseases, November 2012, PLOS

    Dr Rick L Tarleton

  47. Sequential combined treatment with allopurinol and benznidazole in the chronic phase of Trypanosoma cruzi infection: a pilot study

    Article • Journal of Antimicrobial Chemotherapy, October 2012, Oxford University Press (OUP)

    Dr Rick L Tarleton

  48. Is Chagas Disease Really the “New HIV/AIDS of the Americas”?

    Article • PLoS Neglected Tropical Diseases, October 2012, PLOS

    Dr Rick L Tarleton

  49. Kinetoplastids: Trypanosoma cruzi (Chagas disease)

    Article • August 2012, Wiley

    Dr Rick L Tarleton

  50. Inhibitory Receptors Are Expressed by Trypanosoma cruzi-Specific Effector T Cells and in Hearts of Subjects with Chronic Chagas Disease

    Article • PLoS ONE, May 2012, PLOS

    Dr Rick L Tarleton

  51. Transgenic parasites accelerate drug discovery

    Article • Trends in Parasitology, March 2012, Elsevier

    Dr Rick L Tarleton

  52. A Semantic Problem Solving Environment for Integrative Parasite Research: Identification of Intervention Targets for Trypanosoma cruzi

    Article • PLoS Neglected Tropical Diseases, January 2012, PLOS

    Dr Rick L Tarleton

  53. Knockout of the dhfr-ts Gene in Trypanosoma cruzi Generates Attenuated Parasites Able to Confer Protection against a Virulent Challenge

    Article • PLoS Neglected Tropical Diseases, December 2011, PLOS

    Dr Rick L Tarleton

  54. Impact of Aetiological Treatment on Conventional and Multiplex Serology in Chronic Chagas Disease

    Article • PLoS Neglected Tropical Diseases, September 2011, PLOS

    Dr Rick L Tarleton

  55. Report of the 2nd Chagas Drug Discovery Consortium meeting, held on 3 November 2010; Atlanta GA, USA

    Article • Expert Opinion on Drug Discovery, July 2011, Informa Healthcare

    Dr Rick L Tarleton

  56. Oral Exposure to Trypanosoma cruzi Elicits a Systemic CD8+T Cell Response and Protection against Heterotopic Challenge

    Article • Infection and Immunity, May 2011, ASM Journals

    Dr Rick L Tarleton

  57. Methodological advances in drug discovery for Chagas disease

    Article • Expert Opinion on Drug Discovery, March 2011, Informa Healthcare

    Dr Rick L Tarleton

  58. Identification of Contractile Vacuole Proteins in Trypanosoma cruzi

    Article • PLoS ONE, March 2011, PLOS

    Professor Roberto Docampo, Dr Rick L Tarleton

  59. Widespread, focal copy number variations (CNV) and whole chromosome aneuploidies in Trypanosoma cruzi strains revealed by array comparative genomic hybridization

    Article • BMC Genomics, March 2011, Springer Science + Business Media

    Dr Rick L Tarleton

  60. Epigenetic Regulation of Transcription and Virulence in Trypanosoma cruzi by O-Linked Thymine Glucosylation of DNA

    Article • Molecular and Cellular Biology, February 2011, ASM Journals

    Daniel Nilsson, Dr Rick L Tarleton

  61. In Vitro and In Vivo High-Throughput Assays for the Testing of Anti-Trypanosoma cruzi Compounds

    Article • PLoS Neglected Tropical Diseases, July 2010, PLOS

    Dr Rick L Tarleton

  62. CD8+ T Cells Specific for ImmunodominantTrans-Sialidase Epitopes Contribute to Control ofTrypanosoma cruziInfection but Are Not Required for Resistance

    Article • The Journal of Immunology, July 2010, The American Association of Immunologists

    Dr Rick L Tarleton

  63. Generation of Trypanosoma cruzi-Specific CD8+ T-Cell Immunity Is Unaffected by the Absence of Type I Interferon Signaling

    Article • Infection and Immunity, May 2010, ASM Journals

    Dr Rick L Tarleton

  64. Trypanosoma cruzi-specific immune responses in subjects from endemic areas of Chagas disease of Argentina

    Article • Microbes and Infection, May 2010, Elsevier

    Dr Rick L Tarleton

  65. Trypanoside, anti-tuberculosis, leishmanicidal, and cytotoxic activities of tetrahydrobenzothienopyrimidines

    Article • Bioorganic & Medicinal Chemistry, April 2010, Elsevier

    Dr Rick L Tarleton

  66. Changes inTrypanosoma cruzi–Specific Immune Responses after Treatment: Surrogate Markers of Treatment Efficacy

    Article • Clinical Infectious Diseases, December 2009, Oxford University Press (OUP)

    Dr Rick L Tarleton

  67. Chronic Human Infection with Trypanosoma cruzi Drives CD4+ T Cells to Immune Senescence

    Article • The Journal of Immunology, September 2009, The American Association of Immunologists

    Dr Rick L Tarleton

  68. The steady-state transcriptome of the four major life-cycle stages of Trypanosoma cruzi

    Article • BMC Genomics, August 2009, Springer Science + Business Media

    Dr Rick L Tarleton

  69. CD8+ T cells in Trypanosoma cruzi infection

    Article • Current Opinion in Immunology, August 2009, Elsevier

    Dr Rick L Tarleton

  70. Insufficient TLR Activation Contributes to the Slow Development of CD8+ T Cell Responses in Trypanosoma cruzi Infection

    Article • The Journal of Immunology, July 2009, The American Association of Immunologists

    Dr Rick L Tarleton

  71. Chromosome level assembly of the hybrid Trypanosoma cruzi genome

    Article • BMC Genomics, June 2009, Springer Science + Business Media

    Dr Rick L Tarleton

  72. Evaluation of high efficiency gene knockout strategies for Trypanosoma cruzi

    Article • BMC Microbiology, May 2009, Springer Science + Business Media

    Dr Rick L Tarleton

  73. Proteomic analysis of the Trypanosoma cruzi ribosomal proteins

    Article • Biochemical and Biophysical Research Communications, April 2009, Elsevier

    Dr Rick L Tarleton

  74. Ontology-Driven Provenance Management in eScience: An Application in Parasite Research

    Article • January 2009, Springer Science + Business Media

    Dr Rick L Tarleton

  75. High Throughput Selection of Effective Serodiagnostics for Trypanosoma cruzi infection

    Article • PLoS Neglected Tropical Diseases, October 2008, PLOS

    Dr Rick L Tarleton

  76. Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease

    Article • Nature Reports Stem Cells, April 2008, Springer Science + Business Media

    Dr Rick L Tarleton

  77. Kinetoplastids: related protozoan pathogens, different diseases

    Article • Journal of Clinical Investigation, April 2008, American Society for Clinical Investigation

    Professor Alan H Fairlamb, Dr Rick L Tarleton

  78. The Challenges of Chagas Disease— Grim Outlook or Glimmer of Hope?

    Article • PLoS Medicine, December 2007, PLOS

    Dr Rick L Tarleton

  79. Correction: TGF-β regulates pathology but not tissue CD8+ T cell dysfunction during experimentalTrypanosoma cruzi infection

    Article • European Journal of Immunology, December 2007, Wiley

    Dr Rick L Tarleton

  80. TGF-β regulates pathology but not tissue CD8+ T cell dysfunction during experimentalTrypanosoma cruzi infection

    Article • European Journal of Immunology, October 2007, Wiley

    Dr Rick L Tarleton

  81. Immune system recognition of Trypanosoma cruzi

    Article • Current Opinion in Immunology, August 2007, Elsevier

    Dr Rick L Tarleton

  82. A semi-quantitative GeLC-MS analysis of temporal proteome expression in the emerging nosocomial pathogen Ochrobactrum anthropi

    Article • Genome Biology, January 2007, Springer Science + Business Media

    Dr Rick L Tarleton

  83. Multidimensional analysis of the insoluble sub-proteome ofOceanobacillus iheyensis HTE831, an alkaliphilic and halotolerant deep-sea bacterium isolated from the Iheya ridge

    Article • PROTEOMICS, January 2007, Wiley

    Dr Rick L Tarleton

  84. Glycoproteomics ofTrypanosoma cruziTrypomastigotes Using Subcellular Fractionation, Lectin Affinity, and Stable Isotope Labeling

    Article • Journal of Proteome Research, December 2006, American Chemical Society (ACS)

    Dr Rick L Tarleton

  85. Endogenous CD4+ CD25+ Regulatory T Cells Have a Limited Role in the Control of Trypanosoma cruzi Infection in Mice

    Article • Infection and Immunity, November 2006, ASM Journals

    Dr Rick L Tarleton

  86. Limited Role for CD4+ T-Cell Help in the Initial Priming of Trypanosoma cruzi-Specific CD8+ T Cells

    Article • Infection and Immunity, October 2006, ASM Journals

    Dr Rick L Tarleton

  87. Multidimensional Proteomic Analysis of the Soluble Subproteome of the Emerging Nosocomial Pathogen Ochrobactrum anthropi

    Article • Journal of Proteome Research, September 2006, American Chemical Society (ACS)

    Dr Rick L Tarleton

  88. CD8+ T-Cell Responses to Trypanosoma cruzi Are Highly Focused on Strain-Variant trans-Sialidase Epitopes

    Article • PLoS Pathogens, August 2006, PLOS

    Dr Rick L Tarleton

  89. A Combined Shotgun and Multidimensional Proteomic Analysis of the Insoluble Subproteome of the Obligate Thermophile, Geobacillus thermoleovorans T80

    Article • Journal of Proteome Research, August 2006, American Chemical Society (ACS)

    Dr Rick L Tarleton

  90. Analysis of theTrypanosoma cruzicyclophilin gene family and identification of Cyclosporin A binding proteins

    Article • Parasitology, May 2006, Cambridge University Press

    Dr Rick L Tarleton

  91. Trypanosoma cruzi modulates the profile of memory CD8+ T cells in chronic Chagas' disease patients

    Article • International Immunology, January 2006, Oxford University Press (OUP)

    Dr Rick L Tarleton

  92. New approaches in vaccine development for parasitic infections

    Article • Cellular Microbiology, August 2005, Hindawi Publishing Corporation

    Dr Rick L Tarleton

  93. The Genome Sequence of Trypanosoma cruzi, Etiologic Agent of Chagas Disease

    Article • Science, July 2005, American Association for the Advancement of Science

    Professor Elodie Ghedin, Daniel Nilsson, Dr Rick L Tarleton

  94. The Trypanosoma cruzi Proteome

    Article • Science, July 2005, American Association for the Advancement of Science

    Professor Fred R. Opperdoes, Dr Rick L Tarleton

  95. A Heuristic Method for Assigning a False-discovery Rate for Protein Identifications from Mascot Database Search Results

    Article • Molecular & Cellular Proteomics, June 2005, Elsevier

    Dr Rick L Tarleton

  96. Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection

    Article • Immunological Reviews, September 2004, Wiley

    Dr Rick L Tarleton

  97. Inducible Nitric Oxide Synthase Is Not Essential for Control of Trypanosoma cruzi Infection in Mice

    Article • Infection and Immunity, July 2004, ASM Journals

    Dr Rick L Tarleton

  98. Frequency of Interferon‐γ–Producing T Cells Specific forTrypanosoma cruziInversely Correlates with Disease Severity in Chronic Human Chagas Disease

    Article • The Journal of Infectious Diseases, March 2004, Oxford University Press (OUP)

    Dr Rick L Tarleton

  99. Chagas disease: a role for autoimmunity?

    Article • Trends in Parasitology, October 2003, Elsevier

    Dr Rick L Tarleton

  100. Microarray profiling of gene expression during trypomastigote to amastigote transition in Trypanosoma cruzi

    Article • Molecular and Biochemical Parasitology, September 2003, Elsevier

    Dr Rick L Tarleton

  101. Genetic immunization with LYT1 or a pool of trans-sialidase genes protects mice from lethal Trypanosoma cruzi infection

    Article • Vaccine, June 2003, Elsevier

    Dr Rick L Tarleton

  102. Rapid quantitation of Trypanosoma cruzi in host tissue by real-time PCR

    Article • Molecular and Biochemical Parasitology, June 2003, Elsevier

    Dr Rick L Tarleton

  103. Genetic Immunization Elicits Antigen-Specific Protective Immune Responses and Decreases Disease Severity in Trypanosoma cruzi Infection

    Article • Infection and Immunity, October 2002, ASM Journals

    Dr Rick L Tarleton

  104. Parasite genomics: current status and future prospects

    Article • Current Opinion in Immunology, August 2001, Elsevier

    Professor Jessica C Kissinger, Dr Rick L Tarleton

  105. Parasite Persistence Correlates with Disease Severity and Localization in Chronic Chagas' Disease

    Article • The Journal of Infectious Diseases, August 1999, Oxford University Press (OUP)

    Dr Rick L Tarleton

  106. Chagas Disease Etiology: Autoimmunity or Parasite Persistence?

    Article • Parasitology Today, March 1999, Elsevier

    Dr Rick L Tarleton

  107. Molecular cloning of the gene encoding the 83 kDa amastigote surface protein and its identification as a member of the Trypanosoma cruzi sialidase superfamily1Note: Nucleotide sequence data reported in this paper is available in the GenBank™ database u...

    Article • Molecular and Biochemical Parasitology, September 1997, Elsevier

    Dr Rick L Tarleton

  108. Proteins with Glycosylphosphatidylinositol (GPI) Signal Sequences Have Divergent Fates during a GPI Deficiency

    Article • Journal of Biological Chemistry, May 1997, Elsevier

    Dr Rick L Tarleton

  109. The identification and molecular characterization of Trypanosoma cruzi amastigote surface protein-1, a member of the trans-sialidase gene super-family1Note: Nucleotide sequence data reported in this paper is available in the GenBank data base under the...

    Article • Molecular and Biochemical Parasitology, May 1997, Elsevier

    Dr Rick L Tarleton

  110. Persistent Production of Inflammatory and Anti-inflammatory Cytokines and Associated MHC and Adhesion Molecule Expression at the Site of Infection and Disease in ExperimentalTrypanosoma cruziInfections

    Article • Experimental Parasitology, November 1996, Elsevier

    Dr Rick L Tarleton

  111. Characterization of cytokine production in murine Trypanosoma cruzi infection by in situ immunocytochemistry: Lack of association between susceptibility and type 2 cytokine production

    Article • European Journal of Immunology, January 1996, Wiley

    Dr Rick L Tarleton

  112. Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease

    Article • International Immunology, January 1996, Oxford University Press (OUP)

    Dr Rick L Tarleton

  113. Construction and use of a multi-competitor gene for quantitative RT-PCR using existing primer sets

    Article • Journal of Immunological Methods, April 1995, Elsevier

    Dr Rick L Tarleton

  114. The role of T cells in Trypanosoma cruzi infections

    Article • Parasitology Today, January 1995, Elsevier

    Dr Rick L Tarleton

  115. In vitro Culture of Cardiac Mast Cells from Mice Experimentally Infected with <i>Trypanosoma cruzi</i>

    Article • International Archives of Allergy and Immunology, January 1994, Karger Publishers

    Dr Rick L Tarleton

  116. Interleukin 1 activity in haemolymph from strains of the snail biomphalaria glabrata varying in susceptibility to the human blood fluke, Schistosoma mansoni: presence, differential expression, and biological function

    Article • Cytokine, January 1994, Elsevier

    Dr Rick L Tarleton

  117. Trypanosoma cruzi infection suppresses nuclear factors that bind to specific sites on the interleukin

    Article • European Journal of Immunology, January 1994, Wiley

    Dr Rick L Tarleton

  118. Trypanosomes and Microfilariae in Feral Owl and Squirrel Monkeys Maintained in Research Colonies

    Article • American Journal of Tropical Medicine and Hygiene, August 1993, American Society of Tropical Medicine and Hygiene

    Dr Rick L Tarleton

  119. Differentiation of trypanosomatid species by hybridization to selected rRNA probes

    Article • Molecular and Cellular Probes, April 1993, Elsevier

    Dr Rick L Tarleton

  120. Predominance of CD8+ T Lymphocytes in the Inflammatory Lesions of Mice with Acute Trypanosoma cruzi Infection

    Article • American Journal of Tropical Medicine and Hygiene, February 1993, American Society of Tropical Medicine and Hygiene

    Dr Rick L Tarleton

  121. Susceptibility of β2-microglobulin-deficient mice to Trypanosoma cruzi infection

    Article • Nature, March 1992, Springer Science + Business Media

    Dr Rick L Tarleton

  122. Regulation of immunity in Trypanosoma cruzi infection

    Article • Experimental Parasitology, July 1991, Elsevier

    Dr Rick L Tarleton

  123. Differential control of IFN-gamma and IL-2 production during Trypanosoma cruzi infection.

    Article • The Journal of Immunology, May 1991, The American Association of Immunologists

    Dr Rick L Tarleton

  124. Trypanosoma cruzi: Cytokine effects on macrophage trypanocidal activity

    Article • Experimental Parasitology, May 1991, Elsevier

    Dr Rick L Tarleton

  125. Discussion

    Article • Research in Immunology, January 1991, Elsevier

    Dr Rick L Tarleton

  126. The role of T-cell subpopulations in experimental Chagas' disease

    Article • Research in Immunology, January 1991, Elsevier

    Dr Rick L Tarleton

  127. Depletion of CD8+ T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi.

    Article • The Journal of Immunology, January 1990, The American Association of Immunologists

    Dr Rick L Tarleton

  128. Trypanosoma cruzi-induced suppression of IL-2 production. I. Evidence for the presence of IL-2-producing cells.

    Article • The Journal of Immunology, April 1988, The American Association of Immunologists

    Dr Rick L Tarleton

  129. Interleukin 2 production in patients with Chagas' disease: correlation with anti-parasite antibody responses

    Article • Immunology Letters, March 1988, Elsevier

    Dr Rick L Tarleton

  130. A Monoclonal Antibody to Alpha Tubulin Recognizes Host Cell and Trypanosoma cruzi Tubulins1

    Article • The Journal of Protozoology, February 1988, Wiley

    Dr Rick L Tarleton

  131. Initial induction of immunity, followed by suppression of responses to parasite antigens during Trypanosoma cruzi infection of mice

    Article • Parasite Immunology, September 1987, Wiley

    Dr Rick L Tarleton

  132. Biology of tegument associated IgG-Fc and C3 receptors inSchistosoma mansoni

    Article • Journal of Chemical Ecology, August 1986, Springer Science + Business Media

    Dr Rick L Tarleton

  133. Measurement of parasite‐specific immune responses in vitro: evidence for suppression of the antibody response to Trypanosoma cruzi

    Article • European Journal of Immunology, January 1985, Wiley

    Dr Rick L Tarleton

  134. Loss of Suppressor Activity in the Serum of Mice Infected with Trypanosoma cruzi

    Article • Journal of Parasitology, April 1984, JSTOR

    Dr Rick L Tarleton

  135. Diagnosis of Chagas' Disease in Humans Using a Biotin-3H-Avidin Radioimmunoassay *

    Article • American Journal of Tropical Medicine and Hygiene, January 1984, American Society of Tropical Medicine and Hygiene

    Dr Rick L Tarleton

  136. Changes in cell populations and immunoglobulin-producing cells in the spleens of mice infected with Trypanosoma cruzi: Correlations with parasite-specific antibody response

    Article • Cellular Immunology, September 1983, Elsevier

    Dr Rick L Tarleton

  137. Measurement of parasite-specific antibody responses using a tritiated avidin-solid phase radioimmunoassay

    Article • Journal of Immunological Methods, May 1983, Elsevier

    Dr Rick L Tarleton

  138. Trypanosoma cruzi: Effect on B-cell-responsive and -responding clones

    Article • Experimental Parasitology, April 1981, Elsevier

    Dr Rick L Tarleton